Chris Van den Haute Selected Research

Chris Van den Haute Research Topics

Disease

22	Parkinson Disease (Parkinson's Disease) 01/2022 - 08/2006
6	Synucleinopathies 01/2020 - 02/2010
3	Glaucoma 01/2022 - 01/2015
3	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 04/2010
2	Parkinsonian Disorders (Parkinsonism) 03/2021 - 01/2011
2	Kufor-Rakeb syndrome 03/2021 - 07/2015
2	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2021 - 06/2002
2	Seizures (Absence Seizure) 01/2021 - 11/2019
2	Temporal Lobe Epilepsy 01/2021 - 11/2019
2	Neuroinflammatory Diseases 01/2021 - 03/2015
2	Disease Progression 01/2021 - 01/2019
2	Rupture 12/2020 - 01/2020
2	Multiple Sclerosis 01/2020 - 03/2015
2	Cystic Fibrosis (Mucoviscidosis) 01/2016 - 06/2014
1	Melanoma (Melanoma, Malignant) 01/2021
1	Rare Diseases (Rare Disease) 01/2021
1	Pulmonary Arterial Hypertension 01/2021
1	Hypersensitivity (Allergy) 12/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2020
1	Ischemia 11/2020
1	Multiple System Atrophy 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Dementia (Dementias) 01/2020
1	Epilepsy (Aura) 11/2019
1	Cardiac Arrhythmias (Arrythmia) 01/2019
1	Blindness (Hysterical Blindness) 01/2019
1	Vision Disorders (Hemeralopia) 01/2019
1	Ventricular Premature Complexes (Premature Ventricular Contraction) 01/2019
1	Ciliary Motility Disorders (Primary Ciliary Dyskinesia) 01/2016
1	Ocular Hypertension (Glaucoma, Suspect) 01/2015
1	Stroke (Strokes) 09/2014
1	Infarction (Infarctions) 09/2014
1	Neuroblastoma 11/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2011
1	Amyloid Plaque 05/2002
1	Alzheimer Disease (Alzheimer's Disease) 05/2002

Drug/Important Bio-Agent (IBA)

11	alpha-SynucleinIBA 01/2022 - 02/2010
8	SynucleinsIBA 01/2021 - 11/2013
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 05/2002
5	Phosphotransferases (Kinase)IBA 01/2021 - 08/2006
4	PolyaminesIBA 03/2021 - 01/2020
4	Leucine (L-Leucine)FDA Link 01/2021 - 08/2006
2	Retinaldehyde (Retinal)IBA 01/2022 - 01/2019
2	Clozapine (Clozaril)FDA LinkGeneric 01/2021 - 11/2019
2	Pharmaceutical PreparationsIBA 11/2019 - 01/2016
2	Surface-Active Agents (Surfactants)IBA 01/2016 - 06/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 03/2015 - 02/2010
1	RNA (Ribonucleic Acid)IBA 01/2022
1	IronIBA 01/2021
1	Mitoguazone (MGBG)IBA 01/2021
1	Kainic Acid (Kainate)IBA 01/2021
1	Leucine-Rich Repeat Serine-Threonine Protein Kinase-2IBA 01/2021
1	MitoTEMPOIBA 12/2020
1	SpermineIBA 12/2020
1	RotenoneIBA 12/2020
1	Ferritins (Ferritin)IBA 11/2020
1	salicylhydroxamic acid (SHAM)IBA 11/2020
1	Tissue Inhibitor of Metalloproteinase-1IBA 01/2020
1	Glucosylceramides (Glucocerebrosides)IBA 01/2020
1	Cathepsin BIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 11/2019
1	clozapine N-oxideIBA 11/2019
1	Ion Channels (Ion Channel)IBA 01/2019
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2019
1	p21-Activated KinasesIBA 12/2015
1	CuprizoneIBA 10/2015
1	Oncostatin MIBA 10/2015
1	Adenosine Triphosphatases (ATPase)IBA 07/2015
1	LipidsIBA 07/2015
1	Leukemia Inhibitory FactorIBA 03/2015
1	Nerve Growth Factors (Neurotrophins)IBA 01/2015
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2015
1	Neuroprotective AgentsIBA 01/2015
1	Firefly LuciferasesIBA 12/2014
1	NestinIBA 09/2014
1	endonuclease GIBA 11/2013
1	PTEN-induced putative kinaseIBA 04/2011
1	Dopamine (Intropin)FDA LinkGeneric 01/2011
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2011
1	TensinsIBA 01/2011
1	Recombinant ProteinsIBA 04/2010
1	Tacrolimus Binding Proteins (FKBP)IBA 02/2010
1	Oxidopamine (6 Hydroxydopamine)IBA 11/2006
1	Peptides (Polypeptides)IBA 05/2002
1	Amyloid (Amyloid Fibrils)IBA 05/2002
1	Presenilin-1IBA 05/2002

Therapy/Procedure

7	Therapeutics 01/2021 - 09/2014
1	Microspheres (Microsphere) 01/2022
1	Transjugular Intrahepatic Portasystemic Shunt 03/2015
1	Lasers (Laser) 01/2015